Lilla lördag is the weekly life science breakfast seminar where you can listen to inspiring presentations from innovative companies, speakers, and core facilities; catch up and connect with fellow peers across functions; and, of course, enjoy a delicious — and most important — meal of the day while doing all of the above. Each week you also have the chance to tour Novum Forskningspark and the co-working spaces Novum Labs and The Park after the seminar – an excellent place to grow your business or research!

On stage this week: Diamyd Medical

Topic: Precision Immunotherapy in type 1 diabetes

Listen to Diamyd Medical CEOs Ulf Hannelius as he explores type 1 diabetes as a precision immunology disease, highlighting genetic and immune heterogeneity and antigen-specific immune tolerance as a targeted approach. The session includes Phase 3 clinical trial experience evaluating retogatein (rhGAD65), ahead of an interim readout expected in March 2026.

Welcome!